{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T23:11:41Z","timestamp":1662592301147},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1055\/a-1716-8031","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T22:34:24Z","timestamp":1662590064000},"page":"1199-1212","source":"Crossref","is-referenced-by-count":0,"title":["Update: Immunsuppression bei Organtransplantationen"],"prefix":"10.1055","volume":"147","author":[{"given":"Daniela","family":"Kniepeiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00104-014-2883-y","article-title":"[Complication management after liver transplantation: Increasing patient safety by standardized approach and interdisciplinary cooperation]","volume":"86","author":"P Houben","year":"2015","journal-title":"Chirurg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/ajt.13182","article-title":"Renal function in De Novo liver transplant recipients receiving different prolonged-release tacrolimus regimens \u2013 The DIAMOND study","volume":"15","author":"P Trunecka","year":"2015","journal-title":"Am J Transplant"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ajt.13935","article-title":"A steady-state head-tohead pharmacokinetic comparison of all FK 506 (Tacrolimus) formulations (ASTCOFF): an open-label, prospective, randomized, two-arm, three-period study","volume":"17","author":"S Tremblay","year":"2017","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transproceed.2006.10.216","article-title":"Conversion from MMF to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: results from three multicenter studies","volume":"39","author":"F Pietruck","year":"2007","journal-title":"Transplant Proc"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1432-2277.1994.tb01238.x","article-title":"Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver-grafted patient with severe cholestasis","volume":"7","author":"M Winkler","year":"1994","journal-title":"Transpl Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000658-196809000-00009","article-title":"Orthotopic homotransplantation of the human liver","volume":"168","author":"T E Starzl","year":"1968","journal-title":"Ann Surg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2482-14-64","article-title":"Effect of delayed CNI-based immunosuppression with Advagraf \u00ae on liver function after MELD-based liver transplantation (IMUTECT)","volume":"14","author":"S Richter","year":"2014","journal-title":"BMC Surg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1373\/clinchem.2005.052639","article-title":"Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA\u2011DR expression: a multicenter standardized study","volume":"51","author":"W D D\u00f6cke","year":"2005","journal-title":"Clin Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/TP.0b013e3181fecfcb","article-title":"Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of UNOS registry data","volume":"90","author":"J Cai","year":"2010","journal-title":"Transplantation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/lt.23381","article-title":"Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up","volume":"18","author":"R S Mangus","year":"2012","journal-title":"Liver Transpl"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1499-3872(16)60183-2","article-title":"Basiliximab application on liver recipients: a meta-analysis of randomized controlled trials","volume":"16","author":"G Q Zhang","year":"2017","journal-title":"Hepatobil Pancr Dis Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/tri.12100","article-title":"Induction immunosuppression in liver transplantation: a review","volume":"26","author":"A P Turner","year":"2013","journal-title":"Transpl Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/ndt\/gfw086","article-title":"Efficacy and safety of antibody induction therapy in the current era of kidney transplantation","volume":"31","author":"G Opelz","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/ajt.13171","article-title":"Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry","volume":"15","author":"R Adam","year":"2015","journal-title":"Am J Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e3182725532","article-title":"Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring","volume":"95","author":"D R Kuypers","year":"2013","journal-title":"Transplantation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"V C McAlister","year":"2006","journal-title":"Am J Transplant"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e0160421","DOI":"10.1371\/journal.pone.0160421","article-title":"Systematic review and meta-analysis of Tacrolimus versus Ciclosporin as primary immunosuppression after liver transplant","volume":"11","author":"G Muduma","year":"2016","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2012.04140.x","article-title":"Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis","volume":"12","author":"M Rodriguez-Peralvarez","year":"2012","journal-title":"Am J Transplant"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"57505","DOI":"10.18632\/oncotarget.15490","article-title":"Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction","volume":"8","author":"P Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/jlts.2001.23356","article-title":"A randomized doubleblind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients","volume":"7","author":"R Wiesner","year":"2001","journal-title":"Liver Transpl"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/lt.21803","article-title":"Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study","volume":"15","author":"S Karie-Guigues","year":"2009","journal-title":"Liver Transpl"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.TP.0000165118.00988.D7","article-title":"MMF for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results","volume":"80","author":"D J Reich","year":"2005","journal-title":"Transplantation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/liv.12133","article-title":"Calcineurin inhibitors in liver transplantation \u2013 still champions or threatened by serious competitors?","volume":"33","author":"S Beckebaum","year":"2013","journal-title":"Liver Int"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study","volume":"13","author":"F Saliba","year":"2013","journal-title":"Am J Transplant"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"P DeSimone","year":"2012","journal-title":"Am J Transplant"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1097\/TP.0000000000000779","article-title":"Calcineurin inhibitor free de novo immunosuppression in liver transplant recipients with pretransplant renal impairment: results of a pilot study (PATRON07)","volume":"99","author":"A Schnitzbauer","year":"2015","journal-title":"Transplantation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/ctr.12744","article-title":"Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study","volume":"30","author":"M Sterneck","year":"2016","journal-title":"Clin Transplant"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/lt.21396","article-title":"Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials","volume":"14","author":"D L Segev","year":"2008","journal-title":"Liver Transpl"},{"key":"ref29","first-page":"e120939","article-title":"Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression","volume":"10","author":"Y Y Liu","year":"2015","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/lt.22417","article-title":"A randomized, multicentre study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C","volume":"17","author":"G B Klintmalm","year":"2011","journal-title":"Liver Transpl"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MOT.0000000000000391","article-title":"Antibody-mediated rejection: what is the clinical relevance?","volume":"22","author":"R Hogen","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"issue":"S 03","key":"ref32","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends 1994-2004","volume":"6","author":"H U Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"H Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ajt.14186","article-title":"Early conversion from calcineurin inhibitor \u2013 to everolimus-based therapy following kidney transplantation: results of the randomized ELEVATE trial","volume":"17","author":"J W De Fijter","year":"2017","journal-title":"Am J Transplant"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"F Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial","volume":"17","author":"O Thomusch","year":"2016","journal-title":"Lancet"},{"issue":"08","key":"ref38","first-page":"CD005632","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients","author":"M Haller","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/TP.0000000000001195","article-title":"Diagnostic contribution of donor-specific antibody characteristics to uncover late silent antibody-mediated rejection-results of a cross-sectional screening study","volume":"101","author":"F Eskandary","year":"2017","journal-title":"Transplantation"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical Recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report by the consensus on managing modifiable risk in transplantation (COMMIT) group","volume":"101","author":"J Neuberger","year":"2017","journal-title":"Transplantation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-6143.2008.02495.x","article-title":"Nonadherence Consensus Conference Summary Report","volume":"9","author":"R N Fine","year":"2009","journal-title":"Am J Transplant"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10620-012-2412-0","article-title":"Non-adherence and graft failure in adult liver transplant recipients","volume":"58","author":"S R Lieber","year":"2013","journal-title":"Dig Dis Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"J Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.TP.0000109260.00094.01","article-title":"Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A","volume":"15","author":"T Giese","year":"2004","journal-title":"Transplantation"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1716-8031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T22:36:15Z","timestamp":1662590175000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1716-8031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9,7]]},"published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1716-8031","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}